A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China

被引:23
|
作者
Lyu, Jun [1 ]
Li, Zhiying [2 ]
Wei, Huiyi [3 ]
Liu, Dandan [2 ]
Chi, Xiaoxian [2 ]
Gong, Da-Wei [4 ]
Zhao, Qingbin [2 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Clin Res Ctr, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Geratol, Xian 710061, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Middle Sch 2, Xian 710061, Shaanxi, Peoples R China
[4] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA
基金
中国国家自然科学基金;
关键词
Cardiovascular disease; Type 2 diabetes mellitus; Risk predictive model; Northwest China; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; FAMILIAL HYPERCHOLESTEROLEMIA; ELEVATED LIPOPROTEIN(A); VASCULAR COMPLICATIONS; GLUCOSE CONTROL; MORTALITY; HYPERURICEMIA; ATHEROSCLEROSIS;
D O I
10.1007/s00592-020-01484-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Type 2 diabetes mellitus (T2DM) is now very prevalent in China. Due to the lower rate of controlled diabetes in China compared to that in developed countries, there is a higher incidence of serious cardiovascular complications, especially acute coronary syndrome (ACS). The aim of this study was to establish a potent risk predictive model in the economically disadvantaged northwest region of China, which could predict the probability of new-onset ACS in patients with T2DM. Methods Of 456 patients with T2DM admitted to the First Affiliated Hospital of Xi'an Jiaotong University from January 2018 to January 2019 and included in this study, 270 had no ACS, while 186 had newly diagnosed ACS. Overall, 32 demographic characteristics and serum biomarkers of the study patients were analysed. The least absolute shrinkage and selection operator regression was used to select variables, while the multivariate logistic regression was used to establish the predictive model that was presented using a nomogram. The area under the receiver operating characteristics curve (AUC) was used to evaluate the discriminatory capacity of the model. A calibration plot and Hosmer-Lemeshow test were used for the calibration of the predictive model, while the decision curve analysis (DCA) was used to evaluate its clinical validity. Results After random sampling, 319 and 137 T2DM patients were included in the training and validation sets, respectively. The predictive model included age, body mass index, diabetes duration, systolic blood pressure (SBP), diastolic blood pressure (DBP), low-density lipoprotein cholesterol, serum uric acid, lipoprotein(a), hypertension history and alcohol drinking status as predictors. The AUC of the predictive model and that of the internal validation set was 0.830 [95% confidence interval (CI) 0.786-0.874] and 0.827 (95% CI 0.756-0.899), respectively. The predictive model showed very good fitting degree, and DCA demonstrated a clinically effective predictive model. Conclusions A potent risk predictive model was established, which is of great value for the secondary prevention of diabetes. Weight loss, lowering of SBP and blood uric acid levels and appropriate control for DBP may significantly reduce the risk of new-onset ACS in T2DM patients in Northwest China.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 50 条
  • [41] Clinical and morphological characteristics, management and prognosis for acute coronary syndrome in patients with type 2 diabetes mellitus
    Kakorin, S., V
    Kruglyy, L. B.
    Mkrtumyan, A. M.
    DIABETES MELLITUS, 2013, 16 (02): : 36 - 42
  • [42] Management of patients with type 2 diabetes mellitus and acute coronary syndrome: Better be safe than sorry!
    Katsiki, Niki
    Mikhailidis, Dimitri P.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (07) : 465 - 467
  • [43] Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes
    Tao, Jie
    Sang, Dasen
    Zhen, Libo
    Zhang, Xinxin
    Li, Yuejun
    Wang, Guodong
    Chen, Shuohua
    Wu, Shouling
    Zhang, Wenjuan
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [44] Correlation between left ventricular diastolic dysfunction and dyslipidaemia in asymptomatic patients with new-onset type 2 diabetes mellitus
    Ayman, K. M. Hassan
    Mahmoud, A. Abdallah
    Eman, A. Abdel-Mageed
    Marwa, Sayed
    Mona, M. Soliman
    Yehia, T. Kishk
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2021, 33 (01)
  • [45] Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2
    Jax, Thomas W.
    Peters, Ansgar J.
    Plehn, Gunnar
    Schoebel, Frank-Chris
    CARDIOVASCULAR DIABETOLOGY, 2009, 8
  • [46] Prevalence and Risk Factors of Stroke in Inpatients with Type 2 Diabetes Mellitus in China
    Xie, Zuo-ling
    Wang, Chen-chen
    Huang, Xi
    Wang, Zheng
    Shangguan, Hai-yan
    Wang, Shao-hua
    CURRENT MEDICAL SCIENCE, 2024, 44 (04) : 698 - 706
  • [47] Association between new-onset atrial fibrillation and dementia among individuals with type 2 diabetes
    Zhou, Ying
    Xu, Minzhi
    Yin, Xiaoxv
    Gong, Yanhong
    DIABETES OBESITY & METABOLISM, 2024, 26 (09) : 3715 - 3722
  • [48] Predictive factors for new-onset atrial fibrillation in acute coronary syndrome patients undergoing percutaneous coronary intervention
    Zhang, Zhiyuan
    Hu, Chunfang
    Wang, Ruzhu
    Lin, Jie
    Ruan, Zhongbao
    PANMINERVA MEDICA, 2020, 62 (01) : 1 - 6
  • [49] New-onset diabetes mellitus risk associated with concurrent autonomous cortisol secretion in patients with primary aldosteronism
    Wu, Vin-Cent
    Chan, Chieh-Kai
    Wu, Wan-Chen
    Peng, Kang-Yung
    Chang, Yuan-Shian
    Yeh, Fang-Yu
    Chiang, Jiun-Yang
    Lee, Yuan-Ju
    Liu, Kao-Lang
    Wang, Shuo-Meng
    Lin, Yen-Hung
    Chueh, Jeff S.
    TAIPAI Grp
    HYPERTENSION RESEARCH, 2023, 46 (02) : 445 - 455
  • [50] Plasma Calprotectin and New-onset Type 2 Diabetes in the General Population: A Prospective Cohort Study
    Bourgonje, Arno R.
    Bourgonje, Martin F.
    Sokooti, Sara
    la Bastide-van Gemert, Sacha
    Nilsen, Tom
    Hidden, Clara
    Gansevoort, Ron T.
    Mulder, Douwe J.
    Hillebrands, Jan-Luuk
    Bakker, Stephan J. L.
    van Beek, Andre P.
    Dullaart, Robin P. F.
    van Goor, Harry
    Abdulle, Amaal E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 110 (01) : e150 - e159